Capricor Therapeutics CAPR
NASDAQ CAPR
$9.42 +0.14 (+1.51%)
As of: Sep 4, 2026 · 3:12 PM EDT

Capricor Therapeutics (CAPR) Tax Provisions (2025 - 2026)

Analysis

Capricor Therapeutics (CAPR) Tax Provisions (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Vertex Pharmaceuticals 138.58 Bn 130.73 Bn 2.84 Bn 292.00 Mn
2 Regeneron Pharmaceuticals 85.33 Bn 77.33 Bn 3.93 Bn 230.90 Mn
3 Argenx Se 63.43 Bn 58.24 Bn 1.37 Bn -59.00 Mn
4 Moderna 57.84 Bn 52.70 Bn 52.00 Mn 15.00 Mn
5 Revolution Medicines 44.01 Bn 44.01 Bn - -
6 BeOne Medicines 39.93 Bn 34.83 Bn 1.53 Bn 75.45 Mn
7 Alnylam Pharmaceuticals 35.47 Bn 32.16 Bn 992.69 Mn 13.31 Mn
8 Royalty Pharma 28.39 Bn 27.56 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 1.90 Mn
10 Capricor Therapeutics 545.09 Mn 545.09 Mn - 1,600.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1,600.00
Jun 30, 2025 1,600.00